About Amphista

Amphista Therapeutics is an exciting spin out company founded by Advent Life Sciences and built on groundbreaking science from the laboratory of Professor Alessio Ciulli (University of Dundee), a world leader in the field of targeted protein degradation.

Targeted Protein Degradation

Targeted protein degradation (TPD) hijacks the cell’s degradation machinery to modulate abundance of proteins that are responsible for disease progression. Our approach to protein degradation differentiates from traditional TPD technologies and is being developed to treat diseases with high unmet need.

Career Opportunities

We seek exceptional and visionary scientists to join our team working on a cutting-edge therapeutic modality focused on bringing much needed new medicines to patients with life-changing diseases.

Amphista is searching for innovative, and highly motivated individuals who enjoy teamwork and are comfortable working in a fast-paced entrepreneurial environment.

If you feel that your skills and experience are aligned to the opportunities posted, please e-mail your CV directly to recruitment@amphista.com, including the position title in the subject line of your email.